All Clinical Trials

Filter

Results: 2

AmlitelimabA Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

Recruiting

PHASE2

Sponsor:

Sanofi

Location:

Camarillo CA, Lancaster CA, Los Alamitos CA, Denver COshow 21 more

Code:

NCT06557772

Conditions

Coeliac Disease

Celiac Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

SIGE

Gluten-free product (GFP)

Recruiting

Sponsor:

Massachusetts General Hospital